Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Feb 07, 2024 3:44pm
106 Views
Post# 35868270

Let the news filter out, institutional buyers like people

Let the news filter out, institutional buyers like people  As there are 'early adopters' in new technologies or investing in a stock so too there are early adopters of institutions willing to dip their toes into cannabinoid pharmaceuticals.   The collaring algorithm used by IT Virtu Group doesn't even qualify as a pimple on the butt when it comes to instituionals purchasing.   Let's give it some time now between now and when the DEA reschedules.  

Institutional buyers albeit much bigger buyers can take a bit longer to get the internal approvals before their trader makes the purchases.  

Oh, as far as the 'wall' collaring the stock price.....it's forcing the stock price to stay off the radar screens of institutions that review companies and their stock price suddenly 'breaking out' by flashing green with a large percentage price gain.

IT Virtu Group will be playing their 'game' until institutionals overwhelm their algorithm but unfortunately, IT Virtu Group will find out all that work of illegal trading, those gains will be confiscated and they will be fined.   


<< Previous
Bullboard Posts
Next >>